HyTerra Raises $4.07 Million in Rights Issue with Shortfall Correction
HyTerra Ltd has issued 290 million shares through a non-renounceable rights issue, raising $4.07 million, falling short of its $7 million target and leaving a sizeable shortfall of over 209 million shares.
- Issued 290 million shares at $0.014 each
- Raised $4.07 million from entitlement and shortfall acceptances
- Rights issue aimed to raise up to $7 million
- Shortfall corrected to 209.8 million shares unsold
- Offer was not underwritten
Rights Issue Falls Short of Target
HyTerra Ltd (ASX:HYT) has completed a non-renounceable rights issue, issuing 290,491,632 new shares at 1.4 cents each, raising approximately $4.07 million. This falls significantly short of the $7 million maximum the company aimed to raise through the Offer, which allowed eligible shareholders to subscribe for 3 new shares for every 10 held.
The Offer closed on 13 May 2026, and the company confirmed that 282.6 million shares were taken up through entitlement acceptances, with a further 7.9 million shares subscribed via shortfall acceptances. However, a substantial shortfall remains, with 209,821,149 shares still unplaced. This figure corrects a previously disclosed shortfall of 215.9 million shares, reflecting a modest adjustment in the final tally.
Implications of the Unplaced Shortfall
The rights issue was not underwritten, leaving HyTerra exposed to the risk of a lower capital injection than anticipated. The sizeable shortfall raises questions about the company’s immediate funding runway and its plans to place or otherwise manage the remaining shares. The announcement does not clarify how the company intends to address this shortfall or the timing of any further capital raising activities.
HyTerra’s CEO Riley Kemp and Executive Director Avon McIntyre expressed gratitude to shareholders who participated, signalling ongoing shareholder engagement despite the shortfall. The funds raised are expected to support the company’s hydrogen exploration projects, including drilling and data acquisition, as previously outlined in the company’s capital raising plans.
Capital Raise in the Context of Project Development
This rights issue follows HyTerra’s recent push to advance its flagship projects, including the upcoming McCoy-1 production test planned for Q2 2026, which aims to validate hydrogen and helium flow rates. The capital raise was positioned to underpin these operational milestones, as well as ongoing exploration efforts. The shortfall introduces some uncertainty around the pace and scale at which these activities can proceed.
HyTerra’s broader strategy includes collaborations such as the partnership with Prometheus Hydrogen for a US demonstration project and the exclusive pact with Omani operator ARA Natural Resources, both of which require steady funding to maintain momentum. The outcome of this rights issue may influence the company’s ability to capitalise on these opportunities in the near term.
Investors will be watching closely how HyTerra manages the remaining shortfall shares and whether it can secure alternative funding or partnerships to sustain its growth trajectory. The correction in shortfall figures also highlights the importance of precise capital raising disclosures in maintaining market confidence.
Bottom Line?
HyTerra’s partial success in its rights issue raises questions about its funding strategy and the impact on upcoming project milestones.
Questions in the middle?
- How does HyTerra plan to manage or place the remaining 209 million shortfall shares?
- Will the shortfall affect the timing or scale of the McCoy-1 production test and other project activities?
- Could the company seek alternative funding sources or partnerships to bridge the capital gap?
